China's Largest Private Pharma Company Fosun Pharma Targets Biosimilar Market, With Sights On Becoming The Next Teva

Health care reform in the U.S. is a good opportunity for Fosun to gain a foothold in the U.S. market, company chair says at China's first-ever BIO conference.